Medicine and Dentistry
Proteochondroitin Sulfate
100%
Melanoma Cell
100%
Tumor Spheroid
100%
Monoclonal Antibody
100%
Cell Invasion
100%
Cells
87%
Vemurafenib
50%
Therapeutic Procedure
50%
Neoplasm
25%
Nodular Melanoma
25%
Cell Cycle
25%
Colony Formation
25%
Programmed Cell Death
12%
Cell Viability
12%
Ganglioglioma
12%
Melanoma Cell Line
12%
Tumor Cell
12%
WM164 Cell Line
12%
Breast Carcinoma
12%
M14 Cell Line
12%
S Phase
12%
Monoclonal Antibody Therapy
12%
Squamous Cell Carcinoma
12%
Incubation
12%
Cell Cycle M Phase
12%
Analysis
12%
Assay
12%
Aptitude
12%
Tissues
12%
Base
12%
Culture
12%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Monoclonal Antibody
100%
Proteochondroitin Sulfate
100%
Vemurafenib
44%
Neoplasm
33%
Cell Cycle
22%
Base
11%
Glioma
11%
Squamous Cell Carcinoma
11%
Breast Carcinoma
11%
Apoptosis
11%